ENSG00000141027 Expression In 33 Tumors

Ensembl ID Gene symbol Log2 Foldchange Pvaue Cancer
ENSG00000141027 -0.4 5.14e-19 KIRC
ENSG00000141027 -0.6 1.51e-12 COAD
ENSG00000141027 -0.5 1.16e-11 LUSC
ENSG00000141027 -1.1 6.31e-29 LIHC
Ensembl ID Gene symbol Cancer types Pubmed ID
ENSG00000141027 breast cancer 10598586
ENSG00000141027 AML 10688654
ENSG00000141027 breast cancer 10690532
ENSG00000141027 ovarian cancer 11336882
ENSG00000141027 tumor 11430826
ENSG00000141027 tumors 11487586
ENSG00000141027 tumor 11553641
ENSG00000141027 breast tumor 11916237
ENSG00000141027 prostate cancer 12089345
ENSG00000141027 breast tumors 12684393
ENSG00000141027 breast cancer 12725419
ENSG00000141027 tumor 12730327
ENSG00000141027 tumor 14680484
ENSG00000141027 prostate cancer 14744261
ENSG00000141027 prostate tumor 14871982
ENSG00000141027 breast cancer 14980312
ENSG00000141027 breast cancer 15225781
ENSG00000141027 tumour 15300237
ENSG00000141027 breast cancer 15525597
ENSG00000141027 prostate cancer 15598662
ENSG00000141027 tumours 15607539
ENSG00000141027 breast cancer 15788656
ENSG00000141027 breast cancer 15802375
ENSG00000141027 breast cancer 16019133
ENSG00000141027 breast cancer 16141343
ENSG00000141027 breast cancer 16195251
ENSG00000141027 tumor 16309230
ENSG00000141027 prostate cancer 16373395
ENSG00000141027 tumor 16379036
ENSG00000141027 tumors 16479164
ENSG00000141027 breast cancer 16609009
ENSG00000141027 prostate cancer 16886664
ENSG00000141027 breast cancer 17047084
ENSG00000141027 cancer 17312396
ENSG00000141027 tumors 17366602
ENSG00000141027 breast cancer 17407600
ENSG00000141027 thyroid tumor 17606624
ENSG00000141027 colorectal tumors 17630505
ENSG00000141027 prostate cancer 17804755
ENSG00000141027 breast cancer 18521745
ENSG00000141027 tumor 19014961
ENSG00000141027 cancer 19048289
ENSG00000141027 bladder cancer 19126649
ENSG00000141027 breast cancer 19183483
ENSG00000141027 tumors 19735553
ENSG00000141027 breast cancer 19755984
ENSG00000141027 breast cancer 19781322
ENSG00000141027 tumor 20001590
ENSG00000141027 breast cancer 20003447
ENSG00000141027 tumour 20032008
ENSG00000141027 tumor 20052266
ENSG00000141027 prostate cancer 20466759
ENSG00000141027 breast cancer 20567632
ENSG00000141027 prostate cancer 20568894
ENSG00000141027 breast cancer 20696891
ENSG00000141027 liver cancers 21075309
ENSG00000141027 tumor 21143702
ENSG00000141027 bladder cancer 21525722
ENSG00000141027 prostate cancer 21720703
ENSG00000141027 breast cancer 21731475
ENSG00000141027 lung cancer 21966475
ENSG00000141027 AML 22514634
ENSG00000141027 breast cancer 22622808
ENSG00000141027 esophageal cancer 22675025
ENSG00000141027 cancer 22722201
ENSG00000141027 tumors 22820256
ENSG00000141027 prostate cancer 23087083
ENSG00000141027 breast cancer 23098689
ENSG00000141027 prostate cancer 23129261
ENSG00000141027 cancer 23149916
ENSG00000141027 tumor 23295231
ENSG00000141027 tumors 23344024
ENSG00000141027 prostate cancer 23669876
ENSG00000141027 cancer 23755193
ENSG00000141027 Thyroid Cancer 23840792
ENSG00000141027 AML-M5 23940660
ENSG00000141027 tumor 24335696
ENSG00000141027 tumors 24563328
ENSG00000141027 prostate cancer 25189356
ENSG00000141027 cancers 25374920
ENSG00000141027 cancer 25823659
ENSG00000141027 AML 25928846
ENSG00000141027 cancer 25942572
ENSG00000141027 cancers 26117541
ENSG00000141027 tumor 26179601
ENSG00000141027 bladder cancer 26191134
ENSG00000141027 cancers 26246470
ENSG00000141027 acute myeloid leukemia (AML) 26500885
ENSG00000141027 breast cancer 26512648
ENSG00000141027 tumor 26589942
ENSG00000141027 tumor 26729869
ENSG00000141027 tumor 26832397
ENSG00000141027 breast cancer 26920143
ENSG00000141027 Prostate Cancer 26968201
ENSG00000141027 tumors 27023146
ENSG00000141027 cancer 27064257
ENSG00000141027 tumor 27127173
ENSG00000141027 Tumor 27149915
ENSG00000141027 prostate cancer 27340776
ENSG00000141027 breast cancer 27375289
ENSG00000141027 tumour 27499907
ENSG00000141027 bladder tumors 27699256
ENSG00000141027 breast tumors 27806339
ENSG00000141027 ovarian cancers 27822424
ENSG00000141027 triple-negative breast cancer 27880911
ENSG00000141027 prostate cancer 27992601
ENSG00000141027 cancer 28344213
ENSG00000141027 GBM 28356518
ENSG00000141027 GBM 28384648
ENSG00000141027 tumors 28521442
ENSG00000141027 tumor 28631712
ENSG00000141027 tumor 28855213
ENSG00000141027 tumor 28881704
ENSG00000141027 HNSCC 29470550
ENSG00000141027 breast cancer 29535627
ENSG00000141027 cancer 29571661
ENSG00000141027 cancer 29891519
ENSG00000141027 prostate cancer 30255424
ENSG00000141027 tumour 30377343
ENSG00000141027 tumor 30485330
ENSG00000141027 Tumor 30487811
ENSG00000141027 prostate cancer 30828788
ENSG00000141027 cancer 30883028
ENSG00000141027 cancer 31008958
ENSG00000141027 Cancer 31118521
ENSG00000141027 breast cancer 31141879
ENSG00000141027 DLBCL 31197180
ENSG00000141027 tumors 31218271
ENSG00000141027 cancer 31221981
ENSG00000141027 breast cancer 31281520
ENSG00000141027 tumors 31366128
ENSG00000141027 cancer 31427592
ENSG00000141027 non-small cell lung cancer 31661545
ENSG00000141027 Tumor 31850220
ENSG00000141027 Cancer 31932411
ENSG00000141027 tumour 9139821
ENSG00000141027 breast cancer 9501191
ENSG00000141027 AML 9819405
Ensembl ID Gene symbol Disease/phenotype Mutation type Mutated / Total samples Literature
ENSG00000141027 cecum adenocarcinoma missense_variant 9.886% (26/263) 1 entry
ENSG00000141027 Breast Carcinoma by Gene Expression Profile sequence_alteration 6.798% (86/1265) 1 entry
ENSG00000141027 breast ductal adenocarcinoma sequence_alteration 6.424% (111/1728) 2 entries
ENSG00000141027 Breast Carcinoma by Gene Expression Profile frameshift_variant 6.798% (86/1265) 1 entry
ENSG00000141027 colorectal adenocarcinoma frameshift_variant 6.849% (80/1168) 2 entries
ENSG00000141027 breast ductal adenocarcinoma stop_gained 6.424% (111/1728) 2 entries
ENSG00000141027 Breast Carcinoma by Gene Expression Profile stop_gained 6.798% (86/1265) 2 entries
ENSG00000141027 breast ductal adenocarcinoma missense_variant 6.424% (111/1728) 1 entry
ENSG00000141027 cecum adenocarcinoma frameshift_variant 9.886% (26/263) 1 entry
ENSG00000141027 cecum adenocarcinoma stop_gained 9.886% (26/263) 2 entries
ENSG00000141027 colorectal adenocarcinoma sequence_alteration 6.849% (80/1168) 1 entry
ENSG00000141027 colorectal adenocarcinoma stop_gained 6.849% (80/1168) 4 entries
ENSG00000141027 breast ductal adenocarcinoma frameshift_variant 6.424% (111/1728) 4 entries
ENSG00000141027 Breast Carcinoma by Gene Expression Profile missense_variant 6.798% (86/1265) 4 entries
ENSG00000141027 colorectal adenocarcinoma missense_variant 6.849% (80/1168) 4 entries
ENSG00000141027 esophageal adenocarcinoma missense_variant 8.044% (44/547) 1 entry
ENSG00000141027 oral squamous cell carcinoma sequence_alteration 3.788% (10/264) 1 entry
ENSG00000141027 osteosarcoma sequence_alteration 4.605% (7/152) 2 entries
ENSG00000141027 squamous cell lung carcinoma sequence_alteration 2.468% (23/932) 2 entries
ENSG00000141027 small cell lung carcinoma missense_variant 3.401% (15/441) 3 entries
ENSG00000141027 B-cell acute lymphoblastic leukemia missense_variant 3.797% (6/158) 4 entries
ENSG00000141027 prostate carcinoma missense_variant 4.194% (19/453) 5 entries
ENSG00000141027 Gallbladder Adenocarcinoma missense_variant 5.488% (9/164) 2 entries
ENSG00000141027 lobular breast carcinoma frameshift_variant 7.664% (21/274) 1 entry
ENSG00000141027 rectal adenocarcinoma frameshift_variant 1.832% (10/546) 1 entry
ENSG00000141027 prostate adenocarcinoma stop_gained 4.868% (105/2157) 1 entry
ENSG00000141027 Endometrial Endometrioid Adenocarcinoma stop_gained 4.482% (29/647) 1 entry
ENSG00000141027 urothelial carcinoma missense_variant 10.47% (9/86) 1 entry
ENSG00000141027 bronchoalveolar adenocarcinoma missense_variant 13.64% (3/22) 1 entry
ENSG00000141027 prostate adenocarcinoma sequence_alteration 4.868% (105/2157) 3 entries
ENSG00000141027 nasopharyngeal squamous cell carcinoma missense_variant 2.222% (4/180) 2 entries
ENSG00000141027 acute lymphoblastic leukemia sequence_alteration 1.869% (6/321) 1 entry
ENSG00000141027 HER2 Positive Breast Carcinoma frameshift_variant 15.74% (17/108) 1 entry
ENSG00000141027 colon adenocarcinoma sequence_alteration 4.984% (63/1264) 5 entries
ENSG00000141027 lung adenocarcinoma stop_gained 2.204% (56/2541) 2 entries
ENSG00000141027 osteosarcoma missense_variant 4.605% (7/152) 1 entry
ENSG00000141027 skin melanoma sequence_alteration 4.996% (58/1161) 2 entries
ENSG00000141027 lobular breast carcinoma missense_variant 7.664% (21/274) 2 entries
ENSG00000141027 squamous cell lung carcinoma missense_variant 2.468% (23/932) 3 entries
ENSG00000141027 non-small cell lung carcinoma missense_variant 3.125% (3/96) 1 entry
ENSG00000141027 papillary renal cell carcinoma missense_variant 1.55% (6/387) 1 entry
ENSG00000141027 head and neck squamous cell carcinoma missense_variant 2.937% (22/749) 2 entries
ENSG00000141027 basal cell carcinoma missense_variant 13.24% (9/68) 1 entry
ENSG00000141027 laryngeal squamous cell carcinoma missense_variant 7.317% (3/41) 2 entries
ENSG00000141027 prostate adenocarcinoma missense_variant 4.868% (105/2157) 2 entries
ENSG00000141027 pharyngeal squamous cell carcinoma missense_variant 3.704% (3/81) 3 entries
ENSG00000141027 acute lymphoblastic leukemia stop_gained 1.869% (6/321) 1 entry
ENSG00000141027 esophageal squamous cell carcinoma sequence_alteration 2.047% (14/684) 2 entries
ENSG00000141027 bladder transitional cell carcinoma sequence_alteration 5.263% (30/570) 3 entries
ENSG00000141027 hepatocellular carcinoma missense_variant 2.104% (21/998) 2 entries
ENSG00000141027 gastric adenocarcinoma sequence_alteration 3.75% (27/720) 2 entries
ENSG00000141027 gastric adenocarcinoma stop_gained 3.75% (27/720) 1 entry
ENSG00000141027 metaplastic breast carcinoma sequence_alteration 4.839% (3/62) 1 entry
ENSG00000141027 bladder carcinoma sequence_alteration 6.702% (38/567) 1 entry
ENSG00000141027 esophageal squamous cell carcinoma stop_gained 2.047% (14/684) 2 entries
ENSG00000141027 rectal adenocarcinoma stop_gained 1.832% (10/546) 1 entry
ENSG00000141027 HER2 Positive Breast Carcinoma missense_variant 15.74% (17/108) 1 entry
ENSG00000141027 lung adenocarcinoma missense_variant 2.204% (56/2541) 6 entries
ENSG00000141027 bladder carcinoma missense_variant 6.702% (38/567) 1 entry
ENSG00000141027 Breast Carcinoma by Gene Expression Profile conservative_inframe_deletion 6.798% (86/1265) 1 entry
ENSG00000141027 Endometrial Endometrioid Adenocarcinoma sequence_alteration 4.482% (29/647) 1 entry
ENSG00000141027 papillary renal cell carcinoma sequence_alteration 1.55% (6/387) 1 entry
ENSG00000141027 breast carcinoma sequence_alteration 4.037% (69/1709) 3 entries
ENSG00000141027 gastric adenocarcinoma missense_variant 3.75% (27/720) 1 entry
ENSG00000141027 melanoma sequence_alteration 6.897% (10/145) 1 entry
ENSG00000141027 lung adenocarcinoma sequence_alteration 2.204% (56/2541) 3 entries
ENSG00000141027 female breast carcinoma missense_variant 3.901% (11/282) 2 entries
ENSG00000141027 rectal adenocarcinoma missense_variant 1.832% (10/546) 2 entries
ENSG00000141027 pancreatic ductal adenocarcinoma missense_variant 2.852% (48/1683) 2 entries
ENSG00000141027 small cell lung carcinoma sequence_alteration 3.401% (15/441) 3 entries
ENSG00000141027 prostate carcinoma sequence_alteration 4.194% (19/453) 3 entries
ENSG00000141027 endometrium adenocarcinoma frameshift_variant 7.407% (2/27) 1 entry
ENSG00000141027 pancreatic ductal adenocarcinoma sequence_alteration 2.852% (48/1683) 1 entry
ENSG00000141027 skin melanoma stop_gained 4.996% (58/1161) 2 entries
ENSG00000141027 acute myeloid leukemia missense_variant 2.478% (28/1130) 1 entry
ENSG00000141027 lobular breast carcinoma sequence_alteration 7.664% (21/274) 1 entry
ENSG00000141027 Thyroid Gland Undifferentiated (Anaplastic) Carcinoma missense_variant 1.515% (4/264) 2 entries
ENSG00000141027 breast carcinoma missense_variant 4.037% (69/1709) 3 entries
ENSG00000141027 oral squamous cell carcinoma missense_variant 3.788% (10/264) 4 entries
ENSG00000141027 melanoma missense_variant 6.897% (10/145) 2 entries
ENSG00000141027 chronic lymphocytic leukemia sequence_alteration 1.684% (15/891) 2 entries
ENSG00000141027 bladder transitional cell carcinoma missense_variant 5.263% (30/570) 4 entries
ENSG00000141027 urothelial carcinoma stop_gained 10.47% (9/86) 1 entry
ENSG00000141027 Gallbladder Adenocarcinoma sequence_alteration 5.488% (9/164) 1 entry
ENSG00000141027 bladder transitional cell carcinoma frameshift_variant 5.263% (30/570) 1 entry
ENSG00000141027 T-cell acute lymphoblastic leukemia missense_variant 1.305% (5/383) 2 entries
ENSG00000141027 breast carcinoma stop_gained 4.037% (69/1709) 3 entries
ENSG00000141027 skin melanoma missense_variant 4.996% (58/1161) 6 entries
ENSG00000141027 Endometrial Endometrioid Adenocarcinoma missense_variant 4.482% (29/647) 1 entry
ENSG00000141027 Gallbladder Adenocarcinoma stop_gained 5.488% (9/164) 1 entry
ENSG00000141027 breast carcinoma frameshift_variant 4.037% (69/1709) 2 entries
ENSG00000141027 Merkel cell skin cancer missense_variant 3.226% (3/93) 2 entries
ENSG00000141027 rectal adenocarcinoma sequence_alteration 1.832% (10/546) 1 entry
ENSG00000141027 colon adenocarcinoma missense_variant 4.984% (63/1264) 8 entries
ENSG00000141027 brain glioblastoma missense_variant 1.155% (14/1212) 2 entries
ENSG00000141027 lung adenocarcinoma frameshift_variant 2.204% (56/2541) 2 entries
ENSG00000141027 cecum adenocarcinoma sequence_alteration 9.886% (26/263) 1 entry
ENSG00000141027 papillary thyroid carcinoma missense_variant 0.409% (2/489) 1 entry
ENSG00000141027 colon adenocarcinoma frameshift_variant 4.984% (63/1264) 4 entries
ENSG00000141027 clear cell renal carcinoma sequence_alteration 0.8827% (14/1586) 1 entry
ENSG00000141027 clear cell renal carcinoma missense_variant 0.8827% (14/1586) 3 entries
ENSG00000141027 pancreatic neuroendocrine tumor missense_variant 6.78% (16/236) 1 entry
ENSG00000141027 lobular breast carcinoma stop_gained 7.664% (21/274) 2 entries
ENSG00000141027 esophageal squamous cell carcinoma missense_variant 2.047% (14/684) 5 entries
ENSG00000141027 prostate adenocarcinoma frameshift_variant 4.868% (105/2157) 1 entry
ENSG00000141027 T-cell acute lymphoblastic leukemia stop_gained 1.305% (5/383) 1 entry
ENSG00000141027 colon adenocarcinoma stop_gained 4.984% (63/1264) 5 entries
ENSG00000141027 metaplastic breast carcinoma missense_variant 4.839% (3/62) 1 entry
ENSG00000141027 bladder transitional cell carcinoma stop_gained 5.263% (30/570) 2 entries
ENSG00000141027 hepatocellular carcinoma sequence_alteration 2.104% (21/998) 2 entries
ENSG00000141027 female breast carcinoma frameshift_variant 3.901% (11/282) 1 entry
ENSG00000141027 follicular thyroid carcinoma missense_variant 2.899% (2/69) 1 entry
ENSG00000141027 gastric adenocarcinoma frameshift_variant 3.75% (27/720) 1 entry
ENSG00000141027 acute lymphoblastic leukemia frameshift_variant 1.869% (6/321) 1 entry
ENSG00000141027 squamous cell lung carcinoma stop_gained 2.468% (23/932) 1 entry
ENSG00000141027 Appendix Adenocarcinoma missense_variant 1.299% (1/77) 1 entry
ENSG00000141027 multiple myeloma missense_variant 4.444% (2/45) 1 entry
ENSG00000141027 follicular thyroid carcinoma sequence_alteration 2.899% (2/69) 1 entry
ENSG00000141027 small cell lung carcinoma stop_gained 3.401% (15/441) 1 entry
ENSG00000141027 anaplastic oligodendroglioma missense_variant 1.176% (1/85) 1 entry
ENSG00000141027 angiosarcoma missense_variant 4.255% (2/47) 1 entry
ENSG00000141027 prostate carcinoma frameshift_variant 4.194% (19/453) 1 entry
ENSG00000141027 urothelial carcinoma frameshift_variant 10.47% (9/86) 1 entry
ENSG00000141027 ovarian serous adenocarcinoma missense_variant 0.12% (1/833) 1 entry
ENSG00000141027 central nervous system primitive neuroectodermal neoplasm missense_variant 0.6696% (3/448) 1 entry
ENSG00000141027 medullary thyroid gland carcinoma missense_variant 2.778% (1/36) 1 entry
ENSG00000141027 Mixed Lobular and Ductal Breast Carcinoma missense_variant 4.054% (3/74) 1 entry
ENSG00000141027 endometrium adenocarcinoma missense_variant 7.407% (2/27) 1 entry
ENSG00000141027 Endometrial Clear Cell Adenocarcinoma missense_variant 3.704% (1/27) 1 entry
ENSG00000141027 testicular seminoma sequence_alteration 1.282% (1/78) 1 entry
ENSG00000141027 testicular seminoma missense_variant 1.282% (1/78) 1 entry
ENSG00000141027 medullary thyroid gland carcinoma sequence_alteration 2.778% (1/36) 1 entry
ENSG00000141027 clear cell renal carcinoma frameshift_variant 0.8827% (14/1586) 1 entry
ENSG00000141027 gastric intestinal type adenocarcinoma frameshift_variant 3.529% (3/85) 1 entry
ENSG00000141027 squamous cell lung carcinoma frameshift_variant 2.468% (23/932) 1 entry
ENSG00000141027 Ampulla of Vater Carcinoma missense_variant 1.176% (1/85) 1 entry
ENSG00000141027 Endometrial Endometrioid Adenocarcinoma frameshift_variant 4.482% (29/647) 1 entry
ENSG00000141027 Merkel cell skin cancer sequence_alteration 3.226% (3/93) 1 entry
ENSG00000141027 gastric intestinal type adenocarcinoma stop_gained 3.529% (3/85) 1 entry
ENSG00000141027 Tracheal Squamous Cell Carcinoma missense_variant 50.0% (1/2) 1 entry
ENSG00000141027 Mixed Lobular and Ductal Breast Carcinoma frameshift_variant 4.054% (3/74) 1 entry
ENSG00000141027 undifferentiated pleomorphic sarcoma missense_variant 1.613% (1/62) 1 entry
ENSG00000141027 leiomyosarcoma stop_gained 1.0% (1/100) 1 entry
ENSG00000141027 Merkel cell skin cancer stop_gained 3.226% (3/93) 1 entry
ENSG00000141027 Pancreatic Acinar Cell Carcinoma missense_variant 2.941% (1/34) 1 entry
ENSG00000141027 prostate adenocarcinoma conservative_inframe_deletion 4.868% (105/2157) 1 entry
ENSG00000141027 skin carcinoma missense_variant 8.654% (9/104) 1 entry
ENSG00000141027 Mixed Lobular and Ductal Breast Carcinoma stop_gained 4.054% (3/74) 1 entry
ENSG00000141027 Mantle cell lymphoma conservative_inframe_deletion 1.887% (1/53) 1 entry
ENSG00000141027 Thyroid Gland Undifferentiated (Anaplastic) Carcinoma stop_gained 1.515% (4/264) 1 entry
ENSG00000141027 female breast carcinoma stop_gained 3.901% (11/282) 1 entry
ENSG00000141027 small intestinal adenocarcinoma missense_variant 4.762% (1/21) 1 entry
ENSG00000141027 astrocytoma missense_variant 16.67% (1/6) 1 entry
ENSG00000141027 Colorectal Neuroendocrine Tumor G1 stop_gained 20.0% (1/5) 1 entry
ENSG00000141027 Fibroadenoma missense_variant 1.408% (1/71) 1 entry
ENSG00000141027 brain glioblastoma sequence_alteration 1.155% (14/1212) 1 entry
ENSG00000141027 Mantle cell lymphoma missense_variant 1.887% (1/53) 1 entry
ENSG00000141027 mucosal melanoma missense_variant 1.429% (1/70) 1 entry
ENSG00000141027 bile duct adenocarcinoma sequence_alteration 0.5141% (2/389) 1 entry
ENSG00000141027 Anal Squamous Cell Carcinoma frameshift_variant 1.22% (1/82) 1 entry
ENSG00000141027 colon carcinoma frameshift_variant 12.5% (1/8) 1 entry
ENSG00000141027 basal cell carcinoma stop_gained 13.24% (9/68) 1 entry
ENSG00000141027 salivary gland squamous cell carcinoma missense_variant 50.0% (1/2) 1 entry
ENSG00000141027 Peritoneal Mesothelioma frameshift_variant 5.556% (1/18) 1 entry
ENSG00000141027 oligoastrocytoma missense_variant 9.091% (1/11) 1 entry
ENSG00000141027 chromophobe renal cell carcinoma missense_variant 0.6757% (1/148) 1 entry
ENSG00000141027 Endometrial Undifferentiated Carcinoma missense_variant 33.33% (1/3) 1 entry
ENSG00000141027 Fibrolamellar Carcinoma frameshift_variant 5.556% (1/18) 1 entry
ENSG00000141027 renal carcinoma missense_variant 5.0% (1/20) 1 entry
ENSG00000141027 large cell lung carcinoma missense_variant 5.263% (1/19) 1 entry
ENSG00000141027 Invasive Breast Carcinoma stop_gained 2.222% (1/45) 1 entry
ENSG00000141027 Brain Stem Glioblastoma sequence_alteration 1.786% (1/56) 1 entry
ENSG00000141027 angiosarcoma sequence_alteration 4.255% (2/47) 1 entry
ENSG00000141027 salivary gland carcinoma stop_gained 3.03% (1/33) 1 entry
ENSG00000141027 Parathyroid Gland Carcinoma stop_gained 2.857% (1/35) 1 entry
ENSG00000141027 basal cell carcinoma sequence_alteration 13.24% (9/68) 1 entry
ENSG00000141027 urothelial carcinoma conservative_inframe_deletion 10.47% (9/86) 1 entry
ENSG00000141027 Testicular Embryonal Carcinoma conservative_inframe_deletion 4.762% (1/21) 1 entry
ENSG00000141027 brain astrocytoma missense_variant 2.083% (1/48) 1 entry
ENSG00000141027 Sinonasal Undifferentiated Carcinoma missense_variant 8.333% (1/12) 1 entry
ENSG00000141027 diffuse large B-cell lymphoma stop_gained 0.5405% (2/370) 1 entry
ENSG00000141027 bile duct adenocarcinoma missense_variant 0.5141% (2/389) 1 entry
ENSG00000141027 soft tissue sarcoma amino_acid_insertion 0.3413% (1/293) 1 entry
ENSG00000141027 pancreatic ductal adenocarcinoma frameshift_variant 2.852% (48/1683) 1 entry
ENSG00000141027 colon adenocarcinoma conservative_inframe_deletion 4.984% (63/1264) 1 entry
ENSG00000141027 medulloblastoma sequence_alteration 4.167% (1/24) 1 entry
ENSG00000141027 multiple myeloma stop_gained 4.444% (2/45) 1 entry
ENSG00000141027 rectal adenocarcinoma conservative_inframe_deletion 1.832% (10/546) 1 entry
ENSG00000141027 Ovarian Carcinosarcoma missense_variant 8.333% (1/12) 1 entry
ENSG00000141027 anaplastic astrocytoma missense_variant 0.7692% (1/130) 1 entry
ENSG00000141027 breast carcinoma conservative_inframe_deletion 4.037% (69/1709) 1 entry
ENSG00000141027 chronic myelomonocytic leukemia missense_variant 3.704% (1/27) 1 entry
ENSG00000141027 Salivary Gland Carcinoma ex Pleomorphic Adenoma frameshift_variant 4.167% (1/24) 1 entry
ENSG00000141027 large cell medulloblastoma frameshift_variant 5.263% (1/19) 1 entry
ENSG00000141027 brain glioblastoma frameshift_variant 1.155% (14/1212) 1 entry
ENSG00000141027 head and neck squamous cell carcinoma sequence_alteration 2.937% (22/749) 1 entry
ENSG00000141027 pulmonary blastoma frameshift_variant 4.167% (1/24) 1 entry
ENSG00000141027 gastric intestinal type adenocarcinoma missense_variant 3.529% (3/85) 1 entry
ENSG00000141027 neoplasm missense_variant 6.897% (2/29) 1 entry
ENSG00000141027 Duodenal Adenocarcinoma stop_gained 5.882% (1/17) 1 entry
ENSG00000141027 prostate carcinoma conservative_inframe_deletion 4.194% (19/453) 1 entry
ENSG00000141027 Gastric Neuroendocrine Tumor G1 missense_variant 11.11% (1/9) 1 entry
ENSG00000141027 Appendix Goblet Cell Carcinoid missense_variant 4.762% (1/21) 1 entry
ENSG00000141027 adrenocortical adenoma missense_variant 2.439% (1/41) 1 entry
ENSG00000141027 benign blood vessel neoplasm missense_variant 25.0% (1/4) 1 entry
ENSG00000141027 laryngeal squamous cell carcinoma stop_gained 7.317% (3/41) 1 entry
ENSG00000141027 chondroblastoma sequence_alteration 14.29% (1/7) 1 entry
ENSG00000141027 Adrenal Gland Neuroblastoma missense_variant 1.667% (1/60) 1 entry
ENSG00000141027 B-cell acute lymphoblastic leukemia sequence_alteration 3.797% (6/158) 1 entry
Ensembl ID Gene symbol Cancer P-value Which worse show
ENSG00000141027 MESO 0.036 low
ENSG00000141027 SARC 0.046 low
ENSG00000141027 STAD 0.048 low
ENSG00000141027 PAAD 0.038 low
ENSG00000141027 ACC 0.0078 high
ENSG00000141027 LGG 0.00022 high
ENSG00000141027 LUSC 0.011 high
ENSG00000141027 HNSC 0.034 low
ENSG00000141027 READ 0.011 low
ENSG00000141027 KIRP 0.023 low
ENSG00000141027 KICH 0.013 high
ENSG00000141027 PCPG 0.0084 low
ENSG00000141027 THYM 0.024 low
ENSG00000141027 COAD 0.035 high
ENSG00000141027 UCS 0.018 high
ENSG00000141027 DLBC 0.028 high
ENSG00000141027 PRAD 0.0051 high
ENSG00000141027 BLCA 0.032 high
ENSG00000141027 SKCM 0.0059 low
ENSG00000141027 LIHC 0.027 low
Ensembl ID Gene symbol Cancer CNV type -log10(q-value) G-score average amplitude frequency
ENSG00000141027 UCS Del 0.873063 0.214597 0.613463 0.732143
ENSG00000141027 SARC Amp 15.197731 0.761671 1.132070 0.377432
ENSG00000141027 ESCA Del 0.789062 0.099439 0.430292 0.451087
ENSG00000141027 LIHC Del 3.988873 0.110313 0.633926 0.518919
ENSG00000141027 BLCA Del 3.830978 0.121267 0.489662 0.512255
ENSG00000141027 STAD Del 0.641631 0.059411 0.421771 0.390023
ENSG00000141027 UCEC Del 1.952772 0.062870 0.613311 0.246753